Skip to main content

Table 1 Characteristics of the advanced NSCLC patients

From: The stimulatory activity of plasma in patients with advanced non-small cell lung cancer requires TLR-stimulating nucleic acid immunoglobulin complexes and discriminates responsiveness to chemotherapy

Characteristics

n=28

Age (y)

71 ± 76

Gender

 

Female

12

Male

16

Stage

 

III A

3

IIIB

8

IV

17

Histology

 

Adenocarcinoma

11

Squamous carcinoma

9

Not classified carcinoma

8

Mode of therapy

 

CMV

14

MV

9

GC

5

  1. Abbreviations: CMV caboplatin + mitomycin c + Vinblastin, MV mitomycin c + Vinorelbin, GC gemcitabine + cisplatin.
Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us